D-1579-2019 Class II Terminated

Recalled by ImprimisRx NJ — Ledgewood, NJ

FDA drug recall D-1579-2019 was initiated by ImprimisRx NJ on Jul 17, 2019 and is designated Class II. Reason for recall: Subpotent Drug The recall status is terminated (terminated Apr 22, 2020). Affected quantity: 246 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 7, 2019
Initiation Date
Jul 17, 2019
Termination Date
Apr 22, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
246 bottles

Product description

Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRx NJ 1705 Route 46 West, Suite 4, Ledgewood, NJ 07852 (844) 446-6979

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide within the United States

Code information

Lot #: 03132019@2, Exp. 09/17/2019; 05102019@2, Exp. 11/02/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1579-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1579-2019. Report a data issue: hello@regdatalab.com.